198 related articles for article (PubMed ID: 30249614)
41. An 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activity.
Bongers G; Krueger KM; Miller TR; Baranowski JL; Estvander BR; Witte DG; Strakhova MI; van Meer P; Bakker RA; Cowart MD; Hancock AA; Esbenshade TA; Leurs R
J Pharmacol Exp Ther; 2007 Dec; 323(3):888-98. PubMed ID: 17855474
[TBL] [Abstract][Full Text] [Related]
42. Generation of cell lines for drug discovery through random activation of gene expression: application to the human histamine H3 receptor.
Song J; Doucette C; Hanniford D; Hunady K; Wang N; Sherf B; Harrington JJ; Brunden KR; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Jun; 3(3):309-18. PubMed ID: 15971992
[TBL] [Abstract][Full Text] [Related]
43. Discovery of a novel member of the histamine receptor family.
Nguyen T; Shapiro DA; George SR; Setola V; Lee DK; Cheng R; Rauser L; Lee SP; Lynch KR; Roth BL; O'Dowd BF
Mol Pharmacol; 2001 Mar; 59(3):427-33. PubMed ID: 11179435
[TBL] [Abstract][Full Text] [Related]
44. Heteroreceptor Complexes Formed by Dopamine D
Rodríguez-Ruiz M; Moreno E; Moreno-Delgado D; Navarro G; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Franco R
Mol Neurobiol; 2017 Aug; 54(6):4537-4550. PubMed ID: 27370794
[TBL] [Abstract][Full Text] [Related]
45. An Integrated Approach toward NanoBRET Tracers for Analysis of GPCR Ligand Engagement.
Killoran MP; Levin S; Boursier ME; Zimmerman K; Hurst R; Hall MP; Machleidt T; Kirkland TA; Friedman Ohana R
Molecules; 2021 May; 26(10):. PubMed ID: 34065854
[TBL] [Abstract][Full Text] [Related]
46. The naturally occurring mutation Y197C does not affect the expression or signaling of the human histamine H
Flores-Clemente C; Escamilla-Sánchez J; Arias JM; Arias-Montaño JA
Neurosci Lett; 2017 Feb; 641():77-80. PubMed ID: 28126588
[TBL] [Abstract][Full Text] [Related]
47. Histamine H3 and H4 receptors as novel drug targets.
Tiligada E; Zampeli E; Sander K; Stark H
Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
[TBL] [Abstract][Full Text] [Related]
48. Novel naphthyloxy derivatives - Potent histamine H
Łażewska D; Kaleta M; Hagenow S; Mogilski S; Latacz G; Karcz T; Lubelska A; Honkisz E; Handzlik J; Reiner D; Satała G; Filipek B; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2018 May; 26(9):2573-2585. PubMed ID: 29681486
[TBL] [Abstract][Full Text] [Related]
49. Progress in the development of histamine H
Łażewska D; Kieć-Kononowicz K
Expert Opin Ther Pat; 2018 Mar; 28(3):175-196. PubMed ID: 29334795
[TBL] [Abstract][Full Text] [Related]
50. Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology.
Lepailleur A; Freret T; Lemaître S; Boulouard M; Dauphin F; Hinschberger A; Dulin F; Lesnard A; Bureau R; Rault S
J Chem Inf Model; 2014 Jun; 54(6):1773-84. PubMed ID: 24857631
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H
Szczepańska K; Karcz T; Mogilski S; Siwek A; Kuder KJ; Latacz G; Kubacka M; Hagenow S; Lubelska A; Olejarz A; Kotańska M; Sadek B; Stark H; Kieć-Kononowicz K
Eur J Med Chem; 2018 May; 152():223-234. PubMed ID: 29723785
[TBL] [Abstract][Full Text] [Related]
52. NanoB
van den Bor J; Bergkamp ND; Anbuhl SM; Dekker F; Comez D; Perez Almeria CV; Bosma R; White CW; Kilpatrick LE; Hill SJ; Siderius M; Smit MJ; Heukers R
Cell Rep Methods; 2023 Mar; 3(3):100422. PubMed ID: 37056381
[TBL] [Abstract][Full Text] [Related]
53. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets.
Nguyen PL; Cho J
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439898
[TBL] [Abstract][Full Text] [Related]
54. A mini review on biological activities of pyridazinone derivatives as antiulcer, antisecretory, antihistamine and particularly against histamine H3R.
Asif M
Mini Rev Med Chem; 2015; 14(13):1093-103. PubMed ID: 25429662
[TBL] [Abstract][Full Text] [Related]
55. Human basophil chemotaxis and activation are regulated via the histamine H4 receptor.
Mommert S; Kleiner S; Gehring M; Eiz-Vesper B; Stark H; Gutzmer R; Werfel T; Raap U
Allergy; 2016 Sep; 71(9):1264-73. PubMed ID: 26948974
[TBL] [Abstract][Full Text] [Related]
56. The magnificent two: histamine and the H3 receptor as key modulators of striatal circuitry.
Rapanelli M
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Feb; 73():36-40. PubMed ID: 27773554
[TBL] [Abstract][Full Text] [Related]
57. Histamine H3 receptor antagonist decreases cue-induced alcohol reinstatement in mice.
Nuutinen S; Mäki T; Rozov S; Bäckström P; Hyytiä P; Piepponen P; Panula P
Neuropharmacology; 2016 Jul; 106():156-63. PubMed ID: 26107118
[TBL] [Abstract][Full Text] [Related]
58. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
Sadek B; Schwed JS; Subramanian D; Weizel L; Walter M; Adem A; Stark H
Eur J Med Chem; 2014 Apr; 77():269-79. PubMed ID: 24650714
[TBL] [Abstract][Full Text] [Related]
59. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
[TBL] [Abstract][Full Text] [Related]
60. Measuring the rapid kinetics of receptor-ligand interactions in live cells using NanoBRET.
Suchankova A; Harris M; Ladds G
Methods Cell Biol; 2021; 166():1-14. PubMed ID: 34752328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
